Skip to main content
. 2006 May 16;94(10):1504–1509. doi: 10.1038/sj.bjc.6603100

Table 4. Odds ratios for Kaposi's sarcoma among those with two serum samples available for testing, according to whether the first and second sample was sero-positive or negative for latent and lytic anti-KSHV antibodies.

  Latent antibodies
Lytic antibodies
1st sample/2nd sample Number of cases/controls N=118 OR (95% CI) Number of cases/controls N=116 OR (95% CI)
neg/neg 56/89 1.0 71/92 1.0
neg/pos 15/16 1.5 (0.6–3.5) 16/7 3.8 (1.4–10.0)
pos/neg 15/4 9.6 (2.1–43.5) 17/8 2.7 (1.2–6.0)
Pos/pos 32/9 5.5 (2.6–11.6) 12/9 2.2 (0.9–5.1)
    χ 2 (3)=27.9, P<0.001   χ2(3)=11.0, P=0.01